Small intestinal immunopathology and GI-associated antibody formation in hereditary alpha-tryptasemia

• Published in: Journal of allergy and clinical immunology Vol. 148; no. 3; pp. 813 - 821.e7
• Main Authors: Konnikova, Liza, Robinson, Tanya O., Owings, Anna H., Shirley, James F., Davis, Elisabeth, Tang, Ying, Wall, Sarah, Li, Jian, Hasan, Mohammad H., Gharaibeh, Raad Z., Mendoza Alvarez, Lybil B., Ryan, Lisa K., Doty, Andria, Chovanec, Jack F., O’Connell, Michael P., Grunes, Dianne E., Daley, William P., Mayer, Emeran, Chang, Lin, Liu, Julia, Snapper, Scott B., Milner, Joshua D., Glover, Sarah C., Lyons, Jonathan J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.09.2021
• Subjects: Adult; CyTOF; double-negative T cells; Epithelial Cells - immunology; Female; Gastrointestinal Diseases - blood; Gastrointestinal Diseases - genetics; Gastrointestinal Diseases - immunology; Gastrointestinal Diseases - pathology; Genetic Diseases, Inborn - blood; Genetic Diseases, Inborn - genetics; Genetic Diseases, Inborn - immunology; Genetic Diseases, Inborn - pathology; Genotype; hereditary alpha-tryptasemia; Humans; Immunoglobulin G - blood; Immunoglobulin G - immunology; Intestine, Small - cytology; Intestine, Small - immunology; Intestine, Small - pathology; Male; mast cell activation; Mast cells; Mast Cells - immunology; Mastocytosis - blood; Mastocytosis - genetics; Mastocytosis - immunology; Mastocytosis - pathology; memory B cells; Middle Aged; Pyroptosis; small intestine; Tryptases - blood; Tryptases - genetics; Young Adult; mast cell activation; CD; BST; GI; IEC; HαT; IBD; hereditary alpha-tryptasemia; memory B cells; NIH; double-negative T cells; NFI; pyroptosis; MC; IRB; Mast cells; small intestine; IBS; CyTOF
• ISSN: 0091-6749; 1097-6825
• DOI: 10.1016/j.jaci.2021.04.004

Hereditary alpha-tryptasemia (HαT) is characterized by elevated basal serum tryptase due to increased copies of the TPSAB1 gene. Individuals with HαT frequently present with multisystem complaints, including anaphylaxis and seemingly functional gastrointestinal (GI) symptoms. We sought to determine the prevalence of HαT in an irritable bowel syndrome cohort and associated immunologic characteristics that may distinguish patients with HαT from patients without HαT. Tryptase genotyping by droplet digital PCR, flow cytometry, cytometry by time-of-flight, immunohistochemistry, and other molecular biology techniques was used. HαT prevalence in a large irritable bowel syndrome cohort was 5% (N = 8/158). Immunophenotyping of HαT PBMCs (N ≥ 27) revealed increased total and class-switched memory B cells. In the small bowel, expansion of tissue mast cells with expression of CD203c, HLA-DR, and FcεRI, higher intestinal epithelial cell pyroptosis, and increased class-switched memory B cells were observed. IgG profiles in sera from individuals with HαT (N = 21) significantly differed from those in individuals with quiescent Crohn disease (N = 20) and non-HαT controls (N = 19), with increased antibodies directed against GI-associated proteins identified in individuals with HαT. Increased mast cell number and intestinal epithelial cell pyroptosis in the small intestine, and class-switched memory B cells in both the gut and peripheral blood associated with IgG reactive to GI-related proteins, distinguish HαT from functional GI disease. These innate and adaptive immunologic findings identified in association with HαT are suggestive of subclinical intestinal inflammation in symptomatic individuals.